Jbt Marel Corporation · NYSE:JBTM
Jbt Marel — Q3 2026 Earnings Presentation
22 slides from Jbt Marel's earnings presentation, Nov 3, 2026
Slide 1: Q3 2026 Earnings Presentation
Q3 2026 Earnings Presentation November 3, 2026
Slide 2: Non-GAAP and Forward-Looking Statements
NON-GAAP AND FORWARD-LOOKING STATEMENTS Non-GAAP Measures and Reconciliations to GAAP Measures Adjusted EBITDA, Adjusted EBITDA margin, Adjusted income, Adjusted diluted earnings per share (“Adjusted EPS”), and Free cash flow are non-GAAP financial measures. JBT Marel provides non-GAAP financial mea
Slide 3: Q3 2026 Highlights
Q3 2026 Highlights Continued demand for our comprehensive solutions with quarterly consolidated book-to-bill of just below 1x and trailing 4 quarters book-to-bill of 1.05x Solid year-over-year revenue growth in the Protein Solutions segment, which was offset by lower-than-expected book-and-ship reve
Slide 4: Demonstrating Demand Strength and Resiliency of the Recurring Revenue Model
Demonstrating Demand Strength for our Solutions & Resiliency of the Recurring Revenue Model Orders and Backlog Trend Recurring & Non-Recurring Revenue Trend ($ in billions) ($ in millions) Orders Backlog Recurring Revenue Non-Recurring Revenue $1.49 $1.54 $1.52 $1.37 $1.07 $518 $451 $484 $492 $1.04
Slide 5: JBT Marel Consolidated Q3 2026 Financial Performance
JBT Marel Consolidated Q3 2026 Financial Performance Orders Revenue Adj. EBITDA(1) & Margin(1) Adj. EPS(1) ($ in millions) ($ in millions) ($ in millions except margin) $976 $1,001 $994 $2.19 $946 $179 $171 $1.94 18.0% 17.1% Q3 2025 Q3 2026 Q3 2025 Q3 2026 Q3 2025 Q3 2026 Q3 2025 Q3 2026 +3% growth
Slide 6: Protein Solutions Segment Q3 2026 Financial Performance
Protein Solutions Segment Q3 2026 Financial Performance Revenue Adj. EBITDA & Margin Key Takeaways ($ in millions) ($ in millions except margin) $441 $469 $105 ▪ As expected, achieved solid segment organic $94 revenue growth driven by converting strong 22.4% Poultry backlog to revenue 21.3% ▪ Segmen
Slide 7: Prepared Food and Beverage Solutions Segment Q3 2026 Financial Performance
Prepared Food and Beverage Solutions Segment Q3 2026 Financial Performance Revenue Adj. EBITDA & Margin Key Takeaways ($ in millions) ($ in millions except margin) $560 $525 $102 $101 ▪ Segment revenue decline was driven by lower CPG-related book-and-ship volume within the 19.2% 18.3% Diversified Fo
Slide 8: Strong Free Cash Flow Performance & Returns-Based Approach to Capital Allocation
Strong Free Cash Flow Performance & Returns-Based Approach to Capital Allocation Free Cash Flow(1) Performance Capital Allocation Actions ($ in millions) $339 ▪ During Q3 2026, repurchased ~800,000 shares for ~$94M ▪ Strong quarterly free cash flow allowed us to maintain a leverage ratio below 2.5x
Slide 9: Updated Guidance for FY 2026
Updated Guidance for FY 2026 Updated FY 2026 Prior FY 2026 Consolidated In millions except EPS and margin Consolidated Guidance Guidance Revenue $3,950 – $4,000 $3,990 – $4,065 Net Income Margin 5.6% – 6.0% 5.5% – 6.0% Adjusted EBITDA Margin(1) 17.25% – 17.50% 17.0% – 17.5% GAAP diluted EPS $4.30 –
Slide 10: Strategic Initiative Updates
Strategic Initiative Updates
Slide 11: Executing Multiple Levers to Deliver ~$150M in Cost Synergy Savings for FY 2028
Executing Multiple Levers to Deliver ~$150M in Expected Realized Cost Synergy Savings for FY 2028 Run-Rate Cost Synergy Savings In-Year Cost Synergy Savings Through 2028 ($M) 2025 2026E 2027E 2028E Total ~$150M OPEX $24 ~$22 $10 - $15 ~$5 $60 - $65 ~$115M COGS $19 ~$35 $25 - $30 $7 - $10 $85 - $95 T
Slide 12: Phased Approach to Key Footprint Optimization Projects
Phased Approach to Key Footprint Optimization Projects, Allowing Team to Focus on Critical Planning and Execution Key Milestone Achieved Execution Underway 2027 Areas of Focus ▪ Closed 5 manufacturing, distribution, ▪ Began consolidating two adjacent ▪ Consolidate, in phases, two higher- and service
Slide 13: Key Takeaways
Key Takeaways Executing NextGen strategy and on the path to achieve target adjusted EBITDA margin(1) of 20% for FY 2028 Focused integration and phased approach to facility optimization projects provides line of sight to achieve cost synergy savings targets for FY 2028 Benefitting from comprehensive
Slide 14: Appendix
Appendix -- JBT Maret
Slide 15: Non-GAAP Financial Measures
Non-GAAP Financial Measures The non-GAAP financial measures presented in this report may differ from similarly-titled measures used by other companies. The non-GAAP financial measures are not intended to be used as a substitute for, nor should they be considered in isolation of, financial measures p
Slide 16: Reconciliation of Net Income to Adjusted EBITDA
JBT Marel Reconciliation of Net Income to Adjusted EBITDA 16
Slide 17: Reconciliation of Diluted EPS to Adjusted Diluted EPS
JBT Marel Reconciliation of Diluted Earnings Per Share (EPS) to Adjusted Diluted EPS 17
Slide 18: Reconciliation of Cash Provided by Operating Activities to Free Cash Flow
JBT Marel Reconciliation of Cash Provided by Operating Activities to Free Cash Flow (FCF) 18
Slide 19: Leverage Ratio Calculations
JBT Marel Leverage Ratio Calculations 19
Slide 20: Recurring vs. Non-Recurring Revenue
JBT Marel Recurring vs. Non-Recurring Revenue 20
Slide 21: Reconciliation of Diluted EPS to Adjusted Diluted EPS Guidance
JBT Marel Reconciliation of Diluted EPS to Adjusted Diluted EPS Guidance Note: Figures may have immaterial differences due to rounding. 21
Slide 22: Reconciliation of Net Income to Adjusted EBITDA Guidance
JBT Marel Reconciliation of Net Income to Adjusted EBITDA Guidance Note: Figures may have immaterial differences due to rounding. 22